中国药房Issue(26)：3635-3639,5.DOI:10.6039/j.issn.1001-0408.2015.26.10
武汉地区34家医院2011－2013年口服降糖药应用分析
Analysis of the Utilization of Oral Hypoglycemic Agents in 34 Hospitals from Wuhan Area during 2011-2013
丁晶 1刘东1
作者信息
- 1. 华中科技大学同济医学院附属同济医院药学部，武汉 430030
- 折叠
摘要
Abstract
OBJECTIVE:To analyze the utilization and variation tendency of oral hypoglycemic agents in Wuhan area,and to provide reference for drug selection and enterprise production and sale. METHODS:The utilization of oral hypoglycemic agents in 34 hospitals from Wuhan area during 2011-2013 was analyzed statistically in respects of consumption sum,DDDs and DDC etc. RESULTS:The consumption sum and DDDs of oral hypoglycemic agents increased by 20% and 7% respectively year by year. Acarbose had a market share of over 40%. The drug use frequency of metformin ranked the second place only to acarbose. DPP-4 inhibitor had a promising future,with a consumption sum proportion of more than 10%,while the market share of traditional Chi-nese medicine had fallen below 3%. Except for repaglinide,gliclazide,glimepiride,Xiaoke pills,etc.,the selling of other medica-tions are consistent with the user. CONCLUSIONS:The utilization of oral hypoglycemic drugs is basically rational in 34 hospitals from Wuhan area during 2011-2013.关键词
武汉地区/口服降糖药/限定日剂量/用药频度/用药分析Key words
Wuhan area/Oral hypoglycemic agents/DDD/DDDs/Analysis of drug use分类
医药卫生引用本文复制引用
丁晶,刘东..武汉地区34家医院2011－2013年口服降糖药应用分析[J].中国药房,2015,(26):3635-3639,5.
